Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Timing and Dose of Melatonin Administration: a Randomized, Double-blind Controlled Trial in Healthy Adults

NCT07514507 is registered in ClinicalTrials.gov with IRCCS Fondazione Stella Maris as lead sponsor.

NCT NCT07514507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07514507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Timing and Dose of Melatonin Administration: a Randomized, Double-blind Controlled Trial in Healthy Adults
Lead sponsor
IRCCS Fondazione Stella Maris
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 31, 2026
Completion date
August 31, 2026
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sleep disorders